Last updated on March 2018

A clinical trial sponsored by AstraZeneca for a research study of Placebo, Sodium Zirconium Cyclosilicate (ZS) 5g, Sodium Zirconium Cyclosilicate (ZS) 10g

Brief description of study

To evaluate the efficacy of two different doses (5 and 10 g) of ZS orally administered once daily (qd) vs placebo in maintaining normokalemia in initially hyperkalemic patients having achieved normokalemia following two days of initial ZS therapy (10g TID).

Clinical Study Identifier: NCT02875834

Contact Investigators or Research Sites near you

Start Over

Research Site
Yao-shi, Japan